{"id":1064678,"title":"DSEN Abstract: How safe is intravitreal bevacizumab to treat common causes of blindness? Emerging real-world data - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-02","captureTimestamp":"2026-03-02T23:32:19.826000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/52247.html","snippet":"DSEN Abstract How safe is intravitreal bevacizumab to treat common causes of blindness? Emerging real-world data This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following investigators: Sasha Bernatsky and the CAN-AIM research…","rawSnapshotUrl":"/api/snapshots/raw/1064678","browseUrl":"https://replay.healtharchive.ca/job-8/20260302233219/https://cihr-irsc.gc.ca/e/52247.html#ha_snapshot=1064678","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}